Vaccines
Around 40% of the world’s children are immunised against at least one serious disease with a GSK vaccine.
Our success depends on our ability to research and develop innovative vaccines and make them accessible for more people in a responsible way.
| Brand | Active ingredients |
|---|---|
| Boostrix | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
| Cervarix | Human Papillomavirus Vaccine (Types 16 and 18) |
| Havrix | Inactivated Hepatitis A virus Vaccine |
| Infanrix hexa | Diphtheria, tetanus, pertussis (acellular component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed) |
| Priorix | Measles, mumps, rubella vaccine |
| Rotarix | Human Rotavirus Vaccine, Live Attenuated |
| Synflorix | Pneumococcal Polysaccharide and Non-Typeable Haemophilus influenzae (NTHi) Protein D Conjugate Vaccine, Adsorbed |
| Varilrix | Varicella Vaccine, live attenuated |
| Menveo | Meningococcal Group A, C, W135 and Y Conjugate Vaccine |
| Fluarix Tetra | Inactivated Influenza Vaccine (Split Virion) |